
Director of Preventive Cardiology, Director of Cardiometabolic & Lipid Clinic @BaptistFloyd |Chief Cardiology Fellow @UofL |Preventive Cardiology @hopkinsheart|
Louisville, KY
Joined August 2019
- Tweets544
- Following1.9K
- Followers577
- Likes2.2K
Congratulations to Dr. Elisabeth von der Lohe on receiving the 2026 Indiana-ACC Career Achievement Award—a trailblazer as Indiana’s first female interventional cardiologist!
@inacc @drparinpatel @Vijayrao7474
Kunal Jha, MD retweeted
2 yrs ago - @SethShayMartin, Marinos Kosmopoulos, & I were humbled to share Clinicians Choice Award for cleverest NEJM editorial title & final sentence. Too bad NEJM did not link the Fleetwood Mac 🎶 to the outstanding Paul Ridker led research or to our editorial @CiccaroneCenter
Kunal Jha, MD retweeted
Krysta Blaha - 2026-27 - Swimming - William & Mary Athletics - Go Tribe! 🏊🏼♀️ tribeathletics.com/sports/sw…
Kunal Jha, MD retweeted
Congratulations to @inacc's newest Fellows & Associates of the ACC! Your expertise and leadership continue to strengthen cardiovascular care across Indiana. @drparinpatel @Vijayrao7474 @kunaljhamd @LindsayPanah @Andrea_Price317
Kunal Jha, MD retweeted
Our perspective on use of #CAC vs. #CCTA for Guiding Prevention @MichaelJBlaha @WendyPost9
ahajournals.org/doi/10.1161/…
Kunal Jha, MD retweeted
Rita Redberg and Roger Blumenthal Clash Over Statins for Primary Prevention in the Wall Street Journal blogs.nejm.org/cardioexchang…
Kunal Jha, MD retweeted
The MJ23 Professor of Prevention @MichaelJBlaha & 2 of his star @CiccaroneCenter Prevention postdoctoral fellows extraordinaire Drs. Yara Jelwan & Seme Burka @hopkinsheart
Kunal Jha, MD retweeted
Great fun for my Co-Chair @PamelaBMorris & I to celebrate a job well done with members of the Preventive Cardiology Dream Team #ACC26 📷 cred Dr. Wendy Post
Kunal Jha, MD retweeted
Fun @CiccaroneCenter dinner meeting #🥍🐦🫀🏏⚾️⛳️⚽️🎾
Kunal Jha, MD retweeted
What an honor for my Co-Chair @PamelaBMorris & me to Spread The Prevention Mantra @#ACC26 with our colleagues Drs. Don Lloyd-Jones, Heather Johnson, Ann Marie Navar, & @EugeniaGianos! @CiccaroneCenter @HopkinsMedicine @hopkinsheart #/🐦🫀⛳️
Kunal Jha, MD retweeted
1/Ez-PAVE: Trial of LDL lowering to <55 vs <70 in ASCVD.
First came the guidelines-endorsed LDL target of <55 for those with ASCVD (mostly driven by indirect evidence: achieved levels in non-dedicated RCTs & observational studies).
Now comes the evidentiary proof! Or does it?
Big moment for preventive cardiology—Dr. Blumenthal continues to set the standard. Outstanding to see this outstanding team help shape the ’26 Dyslipidemia/Preventive Cardiology Guideline. #AHAEpi26 @rblument1 @MichaelJBlaha @CiccaroneCenter
What a honor to present the ‘26 Dyslipidemia/Preventive 🫀Guideline at #AHAEpi26 meeting with fellow sports fans - my Co-Chair @PamelaBMorris, @RonBlankstein & John Wilkins. #PreventTheEvent #HelpWithImplementation @drstaceyrosen @ChiadiNdumele
1
251
Kunal Jha, MD retweeted
So excited for the presentation of top takeaways from the impactful ACC/AHA/Multisociety Dyslipidemia Guideline by @rblument1 and co-authors at #Epilifestyle26! @PamelaBMorris @RonBlankstein @AHAScience
Excellent discussion of the ‘26 ACC/AHA Dyslipidemia Guideline, with insightful perspectives on risk stratification, individualized therapy, and evolving targets. @rblument1
Dr. Roger Blumenthal and I review top take away messages from the new lipid guidelines
View interview and slides here clinicaltrialresults.org/dr-…
4
203
Kunal Jha, MD retweeted
Many, many thanks to the outstanding writing group of our ‘26 ACC/AHA/Multisociety Dyslipidemia Guideline. It was the professional honor of our lives for my Co-Chair @PamelaBMorris & me to work with this great group of Prevention Intensivists.
Kunal Jha, MD retweeted
Excellent article led by @AlexRazavi the @JoshAllenQB Of 🫀 Disease Prevention & @seamuswhelton @CiccaroneCenter @hopkinsheart #🥍🐦🫀🦬🏈🏀🎾
Aspirin use, lipoprotein(a), and calcific aortic valve disease: the Multi-ethnic Study of Atherosclerosis. Read more in EHJ.
ow.ly/l9mW50YljMj
#EHJ #cardiotwitter #aspirin #aortic #stenosis #lipoprotein(a) @ESC_journals @escardio #AorticValveDisease
Kunal Jha, MD retweeted
🎙️ New episode of The Heart of Prevention coming March 18! 📅
Seeing Atherosclerosis: How Coronary Calcium Transforms Risk Assessment
Join host @Kpakanati3, @khurramn1, and @MichaelJBlaha as they discuss how coronary artery calcium (CAC) scoring is reshaping primary prevention—highlighting the “power of zero” and how CAC helps personalize decisions on statins, aspirin, and more.
🔔 Subscribe: art19.com/shows/the-heart-of…
#PreventiveCardiology #CardioTwitter #CAC #Cardiology #HeartOfPrevention 🎧🫀
Kunal Jha, MD retweeted
🚨 The 2026 ACC/AHA Dyslipidemia Guidelines are here, and CAC scoring just got a Class 1 recommendation for guiding statin therapy decisions in intermediate-risk patients.
Key updates:
➡️ CAC = 0 may allow withholding statins
➡️ CAC ≥100 AU or ≥75th percentile → statin therapy recommended
➡️ CAC ≥1,000 AU → intensive LDL-C targets
➡️ PREVENT-ASCVD equations now guide primary prevention
➡️ Lp(a) testing at least once in a lifetime
Big shift in how we risk-stratify and treat. Worth reading the full guideline. 👇
Key updates to this guideline include:
➡️ The use of the American Heart Association PREVENT-ASCVD equations to guide primary-prevention and lipid-lowering therapy decisions.
➡️ Testing Lp(a) at least once in a lifetime and selective apolipoprotein B measurement to improve risk assessment and guide treatment
➡️ The return of LDL-C and non-high-density lipoprotein cholesterol treatment goals (with lower targets for higher-risk groups)
➡️ Expanded use of coronary artery calcium scoring to reclassify risk[ME1.1]
✍🏼 @rblument1 @tygluckman @RonBlankstein @PamelaBMorris @pnatarajanmd @AnnMarieNavar @SethShayMartin @APRN_CNS @nyulangone @DrMichaelShapir @kgradneyrd @eugeniagianos @virani_md @KellieMcLain1 @ijeomaheartdoc @SamiaMoraMD @DrHeatherJohn @dmljmd
Biological Aging and Valvular Heart Disease: Implications for Risk Str... sciencedirect.com/science/ar…
1
55
Kunal Jha, MD retweeted
Severe obesity (class II-III) shows higher CVD risk, especially for heart failure and atrial fibrillation. The risk of stroke, CVD and all-cause mortality is higher in women. ahajrnls.org/4ruMCVl




























